The chromogranins A and B: The first 25 years and future perspectives, Neuroscience, vol.49, issue.3, pp.497-528, 1992. ,
DOI : 10.1016/0306-4522(92)90222-N
Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract, Virchows Archiv, vol.426, issue.4, pp.361-367, 1995. ,
DOI : 10.1007/BF00191345
Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins, Pathol Res Pract, vol.193, pp.179-185, 1997. ,
Secretoneurin in carcinoids of the appendix-immunohistochemical comparison with chromogranins A, B and secretogranin II, Anticancer Res, vol.18, pp.3999-4002, 1998. ,
Secretogranin II (SgII) distribution and processing studies in human normal and adenomatous anterior pituitaries using new polyclonal antibodies, Regulatory Peptides, vol.68, issue.3, pp.155-163, 1997. ,
DOI : 10.1016/S0167-0115(96)02110-6
Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas, Neuroscience Letters, vol.253, issue.1, pp.17-20, 1998. ,
DOI : 10.1016/S0304-3940(98)00588-6
Immunostaining for vasostatin I distinguishes between ileal and lung carcinoids, The Journal of Pathology, vol.381, issue.3, pp.321-325, 1999. ,
DOI : 10.7326/0003-4819-120-4-199402150-00008
Levels and Molecular Properties of Secretoneurin-Immunoreactivity in the Serum and Urine of Control and Neuroendocrine Tumor Patients, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.1, pp.355-360, 2000. ,
DOI : 10.1210/jc.85.1.355
ELEVATED LEVELS OF SERUM SECRETONEURIN IN PATIENTS WITH THERAPY RESISTANT CARCINOMA OF THE PROSTATE, The Journal of Urology, vol.163, issue.4, pp.1161-1164, 2000. ,
DOI : 10.1016/S0022-5347(05)67714-2
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.244, issue.5259, pp.680-685, 1970. ,
DOI : 10.1101/SQB.1963.028.01.053
Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues, The Histochemical Journal, vol.18, issue.6, pp.473-481, 1995. ,
DOI : 10.1016/0016-5085(88)90374-5
Comparison of chromogranin A, B, and secretogranin II in human adrenal medulla and pheochromocytoma, Lab Invest, vol.57, pp.385-391, 1987. ,
Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas, Histopathology, vol.15, issue.6, pp.527-533, 1993. ,
DOI : 10.1007/BF01675753
Chromogranin A and B and Secretogranin II in Medullary Carcinomas of the Thyroid, The American Journal of Surgical Pathology, vol.11, issue.7, pp.551-556, 1987. ,
DOI : 10.1097/00000478-198707000-00007
Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids, Virchows Archiv A Pathological Anatomy and Histopathology, vol.87, issue.2, pp.103-109, 1987. ,
DOI : 10.1093/ajcp/84.3.273
Impact of chromogranin A measurement in the work-up of neuroendocrine tumors, Annals of Oncology, vol.12, issue.2suppl, pp.79-82, 2001. ,
DOI : 10.1023/A:1012494309486
Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival., Journal of Clinical Investigation, vol.85, issue.5, pp.1555-1559 ,
DOI : 10.1172/JCI114604
, Pancreastatin immunoreactivity in favourable chilhood neuroblastoma and ganglioneuroma, 1995.
, Eur J Cancer, vol.31, pp.557-560
Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms, The American Journal of Surgical Pathology, vol.26, issue.5, pp.551-566, 2002. ,
DOI : 10.1097/00000478-200205000-00002
Malignant Pheochromocytoma : Chromaffin Granule Transmitters and Response to Treatment, Hypertension, vol.36, issue.6, pp.1045-1052, 2000. ,
DOI : 10.1161/01.HYP.36.6.1045
Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?, Proliferative index in phaechromocytomas: does it predict the occurrence of metastases, pp.175-180, 2000. ,
DOI : 10.1002/(SICI)1097-0215(19981023)79:5<537::AID-IJC16>3.0.CO;2-Z
Pheochromocytomas: can malignant potential be predicted?, Urology, vol.53, issue.4, pp.679-683, 1999. ,
DOI : 10.1016/S0090-4295(98)00612-8
Prognostic markers in pheochromocytoma, Prognostic markers in pheochromocytoma, pp.522-526, 1998. ,
DOI : 10.1016/S0046-8177(98)90070-3
Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas, Mod Pathol, vol.12, pp.1107-1111, 1999. ,